Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix

Page created by Regina Taylor
 
CONTINUE READING
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
Anti-PF4-antibodies in VITT
        the Greifswald
                  S. Felix
                           findings
                 Andreas Greinacher
               Institut für Transfusionsmedizin
           Universitätsmedizin Greifswald, Germany

1456
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
Disclosures for Andreas Greinacher

   Research Support/P.I.                                                                               ASPEN
         Employee                                           No relevant conflicts of interest to declare
         Consultant                                       Instrumentation Laboratory; ASPEN; BioKit;
                                                                  MacoPharma; Chromatec
     Major Stockholder                                      No relevant conflicts of interest to declare
      Speakers Bureau                                       No relevant conflicts of interest to declare
         Honoraria                                          No relevant conflicts of interest to declare
  Scientific Advisory Board                                    Instrumentation Laboratory; ASPEN; BioKit

                         Classified as internal/staff & contractors by the European Medicines Agency
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
Structure

• PF4 antibodies in VITT

• PF4 binding partners and VITT

• VITT-like abs independent of Covid-19 vaccination
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
PF4/polyanion IgG ELISA VITT-patients

Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. N Engl J Med. 2021
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
PF4/polyanion antibody ELISA VITT - Patients

                                                                       Platton S, et al JTH 2021                    Vayne C et al NEJM 2021

                                                                                          Summary PF4/polyanion lab tests for VITT:
ORIGINAL ARTICLEs
Anti-PF4 testing for vaccine-induced immune                                               1. ELISA plate based anti-PF4/polyanion assays work but
thrombocytopenia and thrombosis (VITT): Results                                              with different sensitivities
from a NEQAS, ECAT and SSC collaborative exercise in                                      2. Rapid tests, antigen coated on beads are insensitive
385 centers worldwide                                                                        (false neg)
Christopher Reilly-Stitt,Ian Jennings,Steve Kitchen,Mike Makris,Piet Meijer,Moniek de
Maat,Marie Scully,Tamam Bakchoul,Isobel D. Walker
First published: 23 May 2022
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
Nature, prepublished July 07 2021
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
PF4-ELISA reactive antibodies are rather frequent

          Thiele T et al, BLOOD 2021
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
The first VITT patients, March 17, 2021

Warkentin TE, Greinacher A, Laboratory testing of VITT, Semin Hematol 2022
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
Washed platelet assays VITT - Patients

                            Greinacher A et al NEJM 2021
Anti-PF4-antibodies in VITT the Greifswald findings - Andreas Greinacher S. Felix
Crossreactivity of anti-spike antibodies with PF4?

                           Greinacher A et al Blood. 2021 Oct 7;138(14):1269-1277.
Schönborn L., Seck S, Thiele T., Warkentin TE, Greinacher A.
                            New Engl J Med 2022; June 27 epub

Observation in humans

11 VITT patients developed Covid-19
anti-PF4 antibodies before and after Covid-19

Conclusion
Human in-vivo evidence that VITT is neither
related to the spike protein nor to SARS-CoV2
VITT antibodies are transient

              Schönborn L. et al. NEJM 2021; 385(19):1815-1816
              Schönborn et al. BLOOD 2022; ;139(12):1903-1907
Clonal restriction of VITT abs

                               Genetic predisposition?

                       1.   Kanack A, Bayas A, George G, et al. Monoclonal and
                            oligoclonal anti-Platelet Factor 4 antibodies mediate
                            VITT. Blood. 2022 epub.

                       2.   Wang JJ, Armour BL, Ms, Chataway T, et al. Vaccine-
                            induced immune thrombotic thrombocytopenia
                            (VITT) is mediated by a stereotyped clonotypic
                            antibody. Blood. 2022 epub

                       3.   Greinacher A, Nimmerjahn F commentary BLOOD
                            2022, in press
Classified as internal/staff & contractors by the European Medicines Agency   Greinacher A et al. BLOOD 09/2021
PF4 Hexon VITT IgG

                     Greinacher A et al. BLOOD 09/2021
C             D                                     E

    Vaccine                Vaccine + PF4                Vaccine + PF4
                  stained for adenovirus proteins       stained for PF4

                                                        Greinacher A et al. BLOOD 09/2021
PF4 binding partners in VITT

Greinacher A et al. BLOOD 09/2021
                                    Michalik S Haematologica. 2022 Jan 20. doi:10.3324/haematol.2021.280154.
published 02.12.21
VITT beyond vaccination?

  Greinacher A et al Haematologica. 2021 Dec 30. doi: 10.3324/haematol.2021.280366.
Greinacher A et al Haematologica. 2021 Dec 30. doi: 10.3324/haematol.2021.280366.
Summary
• VITT is caused by anti-PF4 antibodies
• VITT antibodies strongly activate platelets, no cofactor required
• The binding partner of PF4 triggering VITT antibodies is still unknown
• VITT antibodies are not triggered by SARS-CoV2 or spike protein
• VITT antibodies are transient
• VITT like antibodies can occur independent of Covid-19 vaccination
Kathleen Selleng        Karin Weisser              Antje Vogelgesang
Jan Wesche              Paul A. Kyrle              Agnes Flöel
Stefan Handtke          Sabine Eichinger           Piero Lovreglio
Raghavendra Palankar    Martina Wolff              Angela Stufano
Konstanze Aurich        Carlo Zaninetti            Rolf Marschalek
Michael Lalk            Lena Ulm                   Brigitte Keller-Stanislawski
Karen Methling          Nils-Olaf Hübner           Emil Reisinger
Uwe Völker              Karsten Becker             Markus Funk
Christian Hentschker    Julia Mayerle              Farid Salih
Stephan Michalik        Sven Reiche                Siegfried Kohler
Leif Steil              Andrea Aebischer           Christiana Franke
Linda Schönborn         Maximilian Muenchhoff      Martin Möckel
Martin Beer             Johannes C. Hellmuth       Thomas Dörner
Kati Franzke            Oliver T. Keppler          Hans C. Bauknecht
Chandini Rangaswamy     Daniel Duerschmied         Christian Pille
Reiner K. Mailer        Achim Lother               Jan A. Graw
Thomas Thiele           Siegbert Rieg              Angelika Alonso
Stefan Kochanek         Meinrad Paul Gawaz         Johann Pelz
Lea Krutzke             Karin Anne Lydia Mueller   Hauke Schneider
Florian Siegerist       Christian S. Scheer        Antonios Bayas
Nicole Endlich          Matthias Napp              Monika Christ
Theodore E. Warkentin   Klaus Hahnenkamp           Joji B. Kuramatsu
Thomas Renne            Guglielmo Lucchese         Matthias Endres
You can also read